BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Synergen Incorporated

Below is an extended Synergen Incorporated patents listing. Click here to return to the Synergen Incorporated main Biocorporate entry.

Synergen Incorporated Patents :

US Patent No.Title
5459048 DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
4760130 Serine protease inhibitors and methods for isolation of same
4994559 Human basic fibroblast growth factor
4997929 Purified ciliary neurotrophic factor
5026839 DNA encoding a basic fibroblast growth factor
5075222 Interleukin-1 inhibitors
5079145 Process for preparing microorganisms used for making phenyl acetyl carlinol (PAC)
5141856 Expression of purified ciliary neurotrophic factor
5188943 Method of producing high molecular weight human fibroblast growth factors
5235043 Production of biologically active, recombinant members of the NGF/BDNF family of neurotrophic proteins
5312742 Process for making L-phenyl acetyl carbinol (PAC), microorganisms for use in the process, and a method of preparing the microorganisms
5332804 High molecular weight human angiogenic basic fibroblast growth factors
5453490 Production of recombinant human interleukin-1 inhibitor
4690897 Method for transformation of anaerobic microorganisms

«Synergen Incorporated

This page contained an extended Synergen Incorporated patents listing. Click here to return to the Synergen Incorporated main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.